Features

Malnutrition and diabetes are two of the most critical health challenges in India. To help address these immediate needs, Abbott is collaborating with Syngene, India's leading contract research organization, to establish its first nutrition research and development (R&D) center in the country.

Abbott has released its 2011 Global Citizenship report. The content-rich online report features videos, photos and examples of how we continue to redefine corporate and social responsibility across our four citizenship priorities: Innovating for the Future, Enhancing Access, Supporting Patients and Consumers, and Safeguarding the Environment.

American Tyson Gay is one of the world’s fastest sprinters. A world-champion, he’s been channeling all his energy and focus on the goal of being at his peak when the Olympic Games begin this summer. And Abbott’s EAS brand sports nutrition products are fueling him every step of the way.

Abbott Molecular has acquired an exclusive license from Stanford University in Palo Alto, California, to develop a diagnostic test in the United States based on several new biomarkers that could address a significant unmet need in determining the prognosis of prostate cancer patients.

The current demographic shift towards an increasingly ageing population in Europe is a major societal and economic challenge for the European Union and its Member States.

Abbott will soon release Phase II data showing its oral treatment regimens for hepatitis C (HCV) compounds have the potential to increase cure rates and shorten the length of treatment with an improved side effect profile.

Abbott Italy has been awarded Top Employer certification by the Corporate Research Foundation (CRF) for four years running.

Expanding Abbott's forensics science presence, our Ibis Biosciences is collaborating with the University of North Texas (UNT) Health Science Center to establish the PLEX-ID analyzer in its forensics lab to analyze human remains in support of missing persons and human trafficking investigations.

Barron's, one of the premier investment publications, once again named Abbott Chairman and CEO Miles White to its annual list of the 30 Most Respected CEOs across all industries.

Forty years ago, Hewlett-Packard introduced the first scientific hand-held calculator. The European Airbus took its first flight. The Volkswagen Beetle became the world’s best-selling car. Nike athletic shoes hit the market. And Abbott put our hepatitis testing on the map.

Abbott's EAS Sports Nutrition brand will be the official performance nutrition recovery provider for 2012 "Tough Mudder" events held in the United States.

Chronic kidney disease (CKD), characterized by a progressive loss of kidney function over time, is a debilitating condition that affects around 10 percent of the worldwide adult population today, and that number is expected to increase as the prevalence of CKD's main risk factors – diabetes, obesity and hypertension – continue to rise.

Afghanistan is among the world’s poorest countries. Everyday life there has borne the scars of war for decades, taking a huge toll on the health of women and children.

Abbott has paid an uninterrupted quarterly dividend to its investors since 1924.

Worldwide, it is estimated that one billion people have a vitamin D deficiency.

Abbott prides itself on being a company that provides employees around the world opportunities to make a difference and advance their careers.

Abbott's XIENCE family of drug eluting stents (which includes XIENCE V®, XIENCE PRIME™ and XIENCE nano™) is the worldwide drug eluting stent market leader for the treatment of coronary artery disease

Partnership announced in connection with coordinated global effort by industry, Gates Foundation, WHO and others.

Abbott's Longford, Ireland, facility has been manufacturing medical diagnostic tests for global markets since 2005.

Abbott delivered its fifth consecutive year of double-digit ongoing earnings per share (EPS) growth with sales increasing more than 10 percent to $38.9 billion in 2011 driven by strong performance across its diverse businesses, particularly in emerging markets.

Abbott Nutrition and the Abbott Fund are teaming with nonprofit organization Partners in Health to fight hunger in Haiti by building a new facility to produce Nourimanba, a peanut-based, therapeutic food for the treatment of severe malnutrition in children.

The U.S. Food and Drug Administration (FDA) has selected Abbott's STARLIMS software-based laboratory information management system (LIMS) as part of an initiative to enhance its own testing laboratories.

Abbott employees continued to expand their support for non-profit groups in 2011, setting new company records for giving.

At the 7th Annual China Corporate Citizenship Conference in Beijing, Abbott recently received several awards for its citizenship work, including the prestigious “2011 China Best Corporate Citizenship Award" for its overall responsible approach to business in China.